How important is dipyridamole in patients with ischemic heart disease?
Spácil, J.
Casopis Lekaru Ceskych 129(18): 570-571
1990
ISSN/ISBN: 0008-7335 PMID: 2350778 Document Number: 350046
Dipyridamol does not have a proven, clinically significant antithrombotic effect. Treatment is relatively expensive. Dipyridamol can cause ischaemia of the heart muscle in patients with ischaemic heart disease. Dipyridamol administration as part of antithrombotic treatment should therefore be selective. Large does can be used as a supplementary loading test for detection of the ischaemic focus.
Document emailed within 1 workday
Related Documents
Spác, J.; Nĕmcová, H.; Blaha, M.; Hlinomaz, O.; Dvorák, I. 1995: The effect of dipyridamole on pulmonary venous flow in patients with ischemic heart disease Vnitrni Lekarstvi 41(5): 298-301Pakulin, I.A.; Surovov, I.A.; Sidorenko, B.A. 1991: Dipyridamole test in the diagnosis of ischemic heart disease Kardiologiia 31(2): 99-100
Zdrenghea, D.; Beudean, M.; Predescu, D.; Bogdan, E.; Ossian, V. 1990: Dipyridamole-exercise association in the diagnosis of ischemic heart disease Medecine Interne 28(3): 235-240
Spác, J.; Nĕmcová, H.; Hlinomaz, O.; Blaha, M.; Dvorák, I. 1996: Importance of dipyridamole transesophageal echocardiography in the diagnosis of ischemic heart disease Vnitrni Lekarstvi 42(8): 528-532
Simorot, V.N. 1986: Significance of the dipyridamole test in diagnosing chronic ischemic heart disease Vrachebnoe Delo 2: 49-53
Gruber, N.; Varga, A.; Forster, T.; Varga, L.; Borthaiser, A.; Csanády, M. 1994: Comparative evaluation of dipyridamole and dobutamine 2-dimensional echocardiography in ischemic heart disease Orvosi Hetilap 135(2): 67-70
Cassone, R.; Moroni, C.; Schillaci, O.; Mammarella, A.; Ierardi, M.; Bondanini, F.; Bossini, A.; Affricano, C.; Scopinaro, F. 1994: Clinical use of echo-dipyridamole test in hypertensive subjects with suspected ischemic heart disease Minerva Cardioangiologica 42(7-8): 327-332
Mandysová, E.; Niederle, P.; Málková, A.; Feuereisl, R.; Jezková, J.; Cervenka, V.; Sládková, T. 1989: The dipyridamole echocardiography test combined with isometric loading in the diagnosis of ischemic heart disease Casopis Lekaru Ceskych 128(21): 652-656
Tarolo, G.L.; Picozzi, R.; Roda, L.; Tramacere, P.L.; Vecchi, C.; Ferrari, A. 1981: Clinical usefulness of thallium-201 myocardial scintigraphy with dipyridamole pharmacodynamic test in ischemic heart disease Giornale Italiano di Cardiologia 11(1): 94-103
Buziashvili, I.I.; Matskeplishvili, S.T.; Asymbekova, E.U.; Khapiĭ, I.K.; Kamardinov, D.K.; Buval'tsev, V.I. 2003: Effect of dipyridamole on blood levels of fibroblast growth factor and vascular endothelial growth factor in patients with ischemic heart disease Kardiologiia 43(6): 14-17
Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40
Shipulin, V.M.; Kazakov, V.A.; Krivoshchekov, E.B.; Sukhodolo, I.V.; Vaizov, V.K.; Lezhnev, A.A.; Stasev, A.N.; Aliab'ev, F.V. 2007: Morphological predictors of postoperative remodeling of the heart in patients with ischemic heart disease Kardiologiia 47(8): 57-59
Chmir, V.P.; Shchepotin, I.B.; Ianovskiĭ, G.V.; Babov, K.D. 1982: Functional state of the heart and blood vessels in patients with ischemic heart disease Vrachebnoe Delo 12: 33-36
Okuneva, G.N.; Cherniavskiĭ, A.M.; Bulatetskaia, L.M.; Voronova, I.P.; Vlasov, I.A.; Boboshko, A.V.; Mironenko, S.P. 2002: Myocardial blood flow in different regions of the heart in patients with ischemic heart disease before and after revascularization Kardiologiia 42(5): 52-55
Ogawa, K.; Nishiwaki, M.; Asada, T.; Mukohara, N.; Higami, T.; Sugimoto, T.; Okada, K. 1991: Analysis of problems in patients over 70 years of age undergoing open-heart surgery for ischemic heart disease Nihon Geka Gakkai Zasshi 92(9): 1115-1118
Soboleva, G.N.; Erpylova, E.A.; Riabykina, G.V.; Sobolev, A.V.; Kozhemiakina, E.Sh.; Fedorova, V.I.; Gorel'tseva, S.Iu.; Karpov, I.A. 2006: Trends in heart rate variability in patients with ischemic heart disease and depression treated with antidepressant tianeptine Terapevticheskii Arkhiv 78(3): 56-60
Dunaev, V.V.; Berezin, A.E. 1998: A comparison of the clinical efficacy of enalapril maleate analogs in patients with heart failure and ischemic heart disease Eksperimental'naia i Klinicheskaia Farmakologiia 61(4): 20-22
Kniazev, M.D.; Gromova, G.V.; Aslibekian, I.S.; Kharlova, L.V.; Kirichenko, A.A. 1982: Health resorts in rehabilitation of patients with ischemic heart disease subjected to the aortocoronary bypass and resection of heart aneurysm Terapevticheskii Arkhiv 54(1): 67-70
Nikolenko, L.A.; Shopova, E.S.; Golovneva, E.S.; Nikolenko, E.S. 2018: Features of red blood indexes in elderly patients with ischemic heart disease and pathology of heart valves before and after surgical correction Kardiologiia 2018(S5): 37-44
Shugushev, K.K.; Eneeva, L.S.; Khadzugov, A.B. 2003: Parameters of spectral-temporal maps of signal averaged ECG in patients with ischemic heart disease and chronic heart failure Kardiologiia 43(9): 8-10